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Abstract
Background: Rift Valley fever is a mosquito-borne zoonotic disease that affects domestic ruminants and humans.
Culex flavivirus is an insect-specific flavivirus that naturally exists in field mosquito populations. The influence of
Culex flavivirus on Rift Valley fever phlebovirus (RVFV) vector competence of Culex pipiens has not been
investigated.
Methods: Culex flavivirus infection in a Cx. pipiens colony was studied by Culex flavivirus oral feeding and
intrathoracical inoculation. Similarly, vector competence of Cx. pipiens infected with Culex flavivirus was evaluated
for RVFV. Infection, dissemination, transmission rates and transmission efficiency of Culex flavivirus-infected and
non-infected Cx. pipiens artificially fed with RVFV infected blood were assessed.
Results: Culex flavivirus was able to infect Cx. pipiens after intrathoracically inoculation in Cx. pipiens mosquitos but
not after Culex flavivirus oral feeding. Culex flavivirus did not affect RVFV infection, dissemination and transmission
in Cx. pipiens mosquitoes. RVFV could be detected from saliva of both the Culex flavivirus-positive and negative Cx.
pipiens females without significant differences. Moreover, RVFV did not interfere with the Culex flavivirus infection in
Cx. pipiens mosquitoes.
Conclusions: Culex flavivirus infected and non-infected Cx. pipiens transmit RVFV. Culex flavivirus existing in
field-collected Cx. pipiens populations does not affect their vector competence for RVFV. Culex flavivirus may
not be an efficient tool for RVFV control in mosquitoes.
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Background
Culex flavivirus (CxFV) belongs to the genus Flavivirus
(family Flaviviridae). The majority of viruses within this
genus are transmitted horizontally between vertebrate
hosts and hematophagous arthropods. However, some
flaviviruses are considered to be vertebrate-specific while
other group of viruses of this genus are insect-specific
(ISFV) [1–3]. Circulation of ISFVs in natural mosquito
populations is likely maintained by vertical transmission
[4, 5]. In Europe, several species of ISFV have been
detected in field mosquitoes from Italy, Portugal, Spain,
the United Kingdom, the Czech Republic and Greece
[6–10]. Sequences related to those viruses have been
detected worldwide [11–14]. ISF RNA has also been de-
tected in sand flies (family Psychodidae) in Algeria [2],
Spain [3] and Portugal (GenBank: HM563684). Previous
field studies in Spain suggested the existence of a large
number of ISF [3, 15, 16], though not completely charac-
terized phylogenetically [10]. The circulation of ISFV in
nature raises concerns regarding possible interactions
with arthropod-borne flaviviruses [17] and even other
arboviruses in vector populations. Co-infection studies
with mosquito-borne flaviviruses (MBFV) and ISFV have
been performed in order to gain a better understanding
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of any factor that could alter vector competence of
mosquitoes for MBFV in both enzootic and epizootic
transmission cycles [18]. Three studies were carried out
to directly address potential co-infection exclusion effect
between CxFV and other flaviviruses such as West Nile
virus (WNV) [18–20]. However, no co-infection studies
with other pathogenic viruses belonging to other genera
have been performed, such as Rift Valley fever phlebo-
virus (RVFV).
Rift Valley fever (RVF) is a mosquito-borne zoonotic
disease caused by RVFV (genus Phlebovirus, family Phe-
nuiviridae). RVFV is transmitted by mosquito bites to a
large number of hosts, both domestic and wild ruminants
[21]. Described for the first time in 1931 in Kenya [22],
RVFV has continuously caused outbreaks in animals and
humans in several African countries [23]. In 2000, RVFV
was first reported outside of Africa, i.e. in Saudi Arabia
and Yemen [24], linking to the likelihood of a potential
introduction of RVFV in Europe. The risk of RVFV intro-
duction in Europe has been recently evaluated [25–28].
Results of a multiple criteria decision-making model study
of key factors for RVF in Spain identified areas with high
suitability for RVF outbreak occurrence in each month of
the year [28]. Moreover, a previous study has shown that a
Culex pipiens mosquito colony from Spain is able to
transmit this virus [29]. Species of the genera Aedes and
Culex are considered main vectors of RVFV [30]. Culex
pipiens complex is considered as an efficient RVFV vector
[31] including Cx. pipiens and Cx. quinquefasciatus which
are ubiquitous mosquitoes in temperate and tropical
regions, respectively [32].
It is relevant to understand ISF dynamics and their
role in their mosquito hosts as potential control tool for
vector-borne pathogens. To this end, the objectives of
the present study were to evaluate (i) the CxFV infection
in a Cx. pipiens colony by oral feeding and intrathoracic
inoculation and (ii) the role in vector competence of
CxFV for RVFV infection, dissemination and transmis-
sion by Cx. pipiens. All experiments were performed
simulating environmental conditions of the season with
high vector density and high suitability for RVF outbreak




One mosquito population of Cx. pipiens pipiens and
molestus hybrid form from Gavà (2012), Catalonia (north-
eastern Spain) was used. Molecular characterization of the
Cx. pipiens forms was performed for each individual in-
volved in the RVFV vector competence assay as previ-
ously described [33]. The Cx. pipiens colony was
reared in laboratory under environmental conditions:
temperature, 26 °C:22 °C (day:night); relative humidity
(RH) of 80%; and a 14:10 h (L:D) photoperiod includ-
ing two crepuscular cycles of 30 min to simulate
dawn and dusk.
Before vector competence assays, the mosquito colony
was tested for the presence of viruses, as described previ-
ously [29], to exclude other viral infections (species of Fla-
vivirus, Alphavirus and Phlebovirus). In the last decade,
other novel insect-specific viruses have been detected in
field mosquitoes belonging to several families such us
Bunyaviridae, Mesoniviridae, Reoviridae, Rhabdoviridae,
Togaviridae and the newly recognized taxon of Nege-
viruses [34]. Prior to vector competence assays, the colony
was also tested for the presence of these viruses using gen-
eric RT-nested-PCR (unpublished) and Wolbachia spp. by
PCR [35]. The mosquito colony was found to be Wolba-
chia spp.-positive and negative for Flavivirus, Alphavirus,
Phlebovirus, Bunyaviridae, Mesoniviridae, Reoviridae,
Rhabdoviridae, Togaviridae and Negeviruses (data not
shown).
Virus strains
The CxFV strain was detected in field-collected Culex
pipiens mosquitoes captured in Huelva, Spain, in 2006,
and isolated in C6/36 cells. To propagate the virus, C6/36
cells were incubated for 6–7 days (28 °C, 5% CO2) and
viral particles were observed by electronic microscopy. As
cytopathic effect was not observed, CxFV replication was
detected in the supernatant using a modified real time
RT-PCR [19] (see below). A monolayer of C6/36 cells was
used to titrate CxFV. Briefly, eight wells were infected for
each ten-fold dilution. Twenty microliters of inoculum
and 150 μl of minimum essential medium (Life Technolo-
gies, Carlsbad, CA, USA) supplemented with 2% FBS
(EuroClone SpA, Pero, Italy), 2 mM L-glutamine, non-
essential amino acids, 1000 U/ml of penicillin, 10 mg/ml
of streptomycin and 500 U/ml of nystatin (all from Sigma-
Aldrich, St. Louis, MO, USA), were added into each well
as post-infection medium. Plates were incubated at 28 °C
and 5% of CO2 for 7 days. Calculation of the viral titer
was performed by virus detection in each well using real
time RT-PCR. Ct-values ranged between 21.09–23.48 in
the wells where the virus replicated. The 50% tissue
culture infective dose per milliliter (TCID50/ml) was cal-
culated using the Reed & Muench method [36].
The virulent RVF 56/74 strain (passages history [37] and
one passage in C6/36 cells) was propagated in BHK-21
cells. The virus was titrated in Vero cells and cytopathic
effect was observed. The 50% tissue culture infective dose
per milliliter (TCID50/ml) was also calculated using the
Reed & Muench method [36].
CxFV infection in mosquitoes orally exposed
Fourteen-day-old Cx. pipiens females were exposed for
60 min to CxFV infected blood (1:2) at 4 log10 TCID50/
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ml using the Hemotek feeder system. At 0, 3, 5, 7 and
10 days post-exposure (dpe), six fed females were
harvested and frozen until analysis.
CxFV intrathoracic inoculation in mosquitoes
A group of 36 Cx. pipiens females, 2–3 days of age, were
intrathoracically inoculated with CxFV at 4 log10TCID50/
ml diluted 1:2 in Dulbecco’s modified Eagle medium
(DMEM). To study virus replication kinetics, these
females were examined at 0, 3, 5, 7, 9 and 11 days post-
inoculation (dpi). Bodies were analyzed from the 36
mosquitoes and saliva was harvested from all mosqui-
toes except from those corresponding to 0 dpi. Saliva
was collected using a capillary technique as previously
described [29]. As an inoculation control, a group of
mosquitoes was inoculated with only DMEM.
RVFV vector competence assay
The ability of RVFV to infect, disseminate and be trans-
mitted by Cx. pipiens infected and non-infected with
CxFV was evaluated by: infection rate (IR), disseminated
infection rate (DIR), transmission rate (TR) and trans-
mission efficiency (TE). IR refers to the proportion of
mosquitoes with infected body among tested mosqui-
toes. DIR corresponds to the proportion of mosquitoes
with infected legs/wings among the previously detected
infected mosquitoes (i.e. body positive). TR represents
the proportion of mosquitoes with infected saliva among
mosquitoes with disseminated infection. TE represents
the proportion of mosquitoes with infected saliva among
the total number of mosquitoes tested [38].
Seven- to nine-day-old female mosquitoes that had
never been blood-fed were used. Mosquitoes were reared
and fed as previously described [29]. Culex pipiens intra-
thoracically inoculated with CxFV or with DMEM were
tested for vector competence (VC) using a RVFV viral
dose of 7.23 log10TCID50/ml. After the blood-feeding,
CO2 was used to anesthetize the mosquitoes and fully-
engorged females (FEF) were selected. The blood doped
with RVFV was titrated in Vero cells. Ten percent of the
specimens from each group were sacrificed and analyzed
as a control of the inoculum. The rest of the mosquitoes
were individually placed to cardboard cages (Watkins &
Doncaster, Leominster, UK).
FEF were fed with sucrose (10%) ad libitum using
soaked cotton pledgets. The presence of viral RNA in
saliva was evaluated using two different approaches:
FTATM cards (GE Healthcare, Little Chalfont, UK)
soaked with Manuka honey (Manuka Health New
Zealand, Te Awamutu, New Zealand) and a blue
alimentary colorant, at 4 and 14 dpe and the direct
extraction of mosquitoes’ saliva by capillarity at 14 dpe.
At 4 and 14 dpe the FTA cards were left 24 h on the top
of the mesh screen of all cardboard cages to allow the
mosquito to feed on it. After FTA cards collection, they
were resuspended in 0.3 ml of PBS and stored at -80 °C
until tested. At 14 dpe, every mosquito was anesthetized
with CO2 and dissected, and samples (legs/wings and
bodies) were collected as previously described [29]. One
hundred-fifty microliters from the saliva sample
contained in DMEM medium were used for viral RNA
extraction and the remaining 50 μl were used for RVFV
isolation in a Vero cells monolayer. Cells were incubated
for 7 days (37 °C, 5% CO2) and the cytophatic effect was
evaluated.
Virus detection
CxFV detection was performed using the real time RT-PCR
protocol described by Bolling et al. [19] with minor modifi-
cations. The primer CxFV-F was modified as follows: 5'-
CTA CGC TCT TAA CAC AGT GA-3' and RT-qPCR was
carried out using Quantitec SyBr Green RT-PCR kit
(Qiagen, Hilden, Germany). Samples were amplified using a
7500 Fast Real-Time PCR System (Applied Biosystems,
Foster City, CA, USA) programmed as follows: 50 °C for 10
min, 95 °C for 10 min, 45 cycles at 95 °C for 15 s and at 57
°C for 35 s. RVFV RNA was extracted and detected as
previously described [29].
Statistical analysis
The frequency with which CxFV (+) and CxFV (-) mos-
quitoes get infected, disseminate, and transmit RVFV
was compared by Fisher’s exact test. Ct-values in
mosquito bodies, legs/wings and saliva 14 dpe were
compared between CxFV (+) and CxFV (-) groups by
a non-parametric Mann-Whitney test as data were
not normally distributed. Differences in Ct-values in
CxFV inoculated mosquitoes among dpi were assessed
by means of a multiple comparisons Kruskal-Wallis
test. P-values < 0.05 were considered statistically
significant.
Results
CxFV replication kinetics in orally exposed Cx. pipiens
No CxFV replication was detected in Cx. pipiens
exposed orally, suggesting that Cx. pipiens mosquitoes
are not susceptible to CxFV infection by oral exposure.
Although no positive CxFV was recorded in any tested
female mosquito on 3, 5, 7 and 10 dpe, CxFV could be
detected in all mosquito samples collected on 0 dpe,
demonstrating that all mosquitoes were exposed to the
virus (Fig. 1).
CxFV replication kinetics in Cx. pipiens intrathoracically
inoculated
Culex pipiens intrathoracically inoculated with CxFV
showed viral replication. Results demonstrated a high per-
centage of CxFV infection detected at all time-points
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analyzed. The obtained Ct-values were high, indicating low
viral load. However, the multiple comparison Kruskall-
Wallis test detected significant differences in viral loads
among dpi (H = 16.692, df = 5, P = 0.005). The mul-
tiple comparisons of mean ranks indicated that the
viral load in bodies of females tested at 7and 9 dpi
was significantly higher than at 0 dpi (z = 3.33, P =
0.012 and z = 3.06, P = 0.033, respectively), showing
CxFV replication within Cx. pipiens after intrathoracic
inoculation (Fig. 2). All saliva samples tested at diffe-
rent time points were negative to CxFV.
CxFV replication kinetics in Cx. pipiens co-infected with RVFV
CxFV replication was not affected by RVFV exposure
in female Cx pipiens mosquitoes. Results showed that
21 days after CxFV inoculation and 14 days after
RVFV exposure (14 dpe), bodies of all tested females
remained positive to CxFV without significant differ-
ences (Fig. 3).
RVFV infection, dissemination and transmission in Cx.
pipiens infected and non-infected with CxFV
Mosquitoes infected with CxFV and exposed to
RVFV (n = 10; n = 1 hybrid form and n = 9 moles-
tus form) and mosquitoes non-infected with CxFV
and exposed to RVFV (n = 22; n = 5 hybrid form
and n = 17 molestus form) were analyzed at 14 dpe.
The percentages of RVFV infection, dissemination
and transmission in analyzed mosquito females were
not significantly different between females infected
and non-infected with CxFV (Table 1). Moreover,
RVFV loads in bodies and legs/wings were not sig-
nificantly different between females infected and
non-infected with CxFV (Fig. 4).
All RVFV-positive saliva were detected in females with
disseminated infection at 14 dpe. The Ct-values in mos-
quito saliva did not differ significantly between both
groups, infected and non-infected with CxFV (Table 2).
In addition, RVFV was detected in bodies, legs/wings or
Fig. 1 CxFV replication kinetics in Cx. pipiens oral infection. Cx. pipiens mosquitoes were not susceptible to CxFV infection following oral exposure.
Columns show infection percentages and the line represents the Ct-values obtained by RT-qPCR. Abbreviation: dpe, days post-exposure
Fig. 2 CxFV replication kinetics in Cx. pipiens intrathoracilally inoculated. Cx. pipiens mosquitoes were susceptible to CxFV infection after
intrathoracic inoculation. Columns show infection percentages and the line represents the Ct-values obtained by RT-qPCR. Abbreviation: dpi,
days post-inoculation
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saliva of mosquitoes with (n = 27) and without (n = 5)
Wolbachia (Table 2).
Regarding the forms of individuals from the Cx.
pipiens hybrid colony, RVFV was detected in mosquito
bodies, legs/wings and saliva of Cx. pipiens form moles-
tus and in mosquito bodies of the hybrid form (Table 3).
Discussion
The isolation, identification and characterization of
numerous insect-specific viruses in recent years are of
particular interest. They can coexist with pathogenic
arboviruses in mosquito populations and may poten-
tially affect the transmission of vector-borne infec-
tious diseases. While there is extensive genetic and
phenotypic characterization of insect-specific flavi-
viruses, little is known about the interactions between
them and their mosquito hosts and other arboviruses
and the potential public health significance of these
associations [39]. Relatively few studies have been per-
formed on co-infections with other flaviviruses such
as WNV [18–20]. To the best of our knowledge, the
present study is the first to perform a co-infection
with two viruses from different genera, CxFV (Flavivi-
rus) and RVFV (Phlebovirus).
The mechanism through which natural mosquito popu-
lations become infected with CxFV is not yet well defined.
Our results strongly suggest that Cx. pipiens females are
not susceptible to CxFV upon oral exposure. This is in
agreement with previous studies showing transmission of
insect-specific viruses solely among their invertebrate
hosts by vertical route [1, 5]. Intrathoracic inoculation of
CxFV in our study, however, indicates that the virus may
have the potential to replicate in Cx. pipiens females at
least for 21 days, establishing a possible CxFV persistent
infection. Nevertheless, CxFV could not be detected in
saliva after 14 dpi. Our results are in line with a previous
report by Kent et al. [20] who showed that CxFV Izabal
intrathoracically inoculated to Cx. quinquefasciatus
females was not found in the saliva.
Vector competence for RVFV was examined at 14 dpe
in one Cx. pipiens colony artificially infected with CxFV
by intrathoracic inoculation. The percentage of mosquito
females that became infected, developed a disseminated
infection, and transmitted RVFV was not significantly
different between females infected and non-infected with
CxFV. We assume that CxFV may have co-evolved with
their mosquito host evading their immune system with-
out affecting its function against a subsequently-
infecting virus. As such, the molecular mechanisms that
allow co-existence of both CxFV and RVFV are not well
defined and need more extensive studies. Furthermore,
RVFV RNA levels observed were also not significantly
different suggesting that CxFV does not affect RVFV
replication. This is in agreement with other published
studies where co-infection of CxFv and WNV has been
performed. Similarly, Kent et al. [20] investigated the
vector competence for WNV of Cx. quinquefasciatus
mosquitoes intrathoracically inoculated with CxFV
Izabal, and also observed no significant differences in
WNV titers between CxFV-positive and CxFV-negative
mosquitoes at 14 dpi. Another study that tested the vec-
tor competence for WNV in two Cx. pipiens colonies
[19], one colony CxFV naturally infected and the other
CxFV non-infected, reported no significant differences
in WNV dissemination between both colonies at 14 dpe.
However, significant differences were observed at 7 dpe,
Fig. 3 CxFV replication kinetics in co-infection with RVFV in Cx. pipiens. CxFV persisted after 21 dpi and was not influenced by RVFV exposure.
Columns show infection percentages and the line represents the Ct-values obtained by RT-qPCR
Table 1 RVFV infection, dissemination and transmission in Cx.
pipiens infected and non-infected with CxFV
CxFV infection IRg DR TR TE
+ 5/10 (50%) 2/5 (40%) 1/2 (50%) 1/10 (10%)
- 15/22 (68%) 5/15 (33%) 4/5 (80%) 4/22 (18%)
Abbreviations: IR infection rate, DR disseminated infection rate, TR transmission
rate, TE transmission efficiency
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being significantly higher in the CxFV-negative colony
than in CxFV-positive colony. These results suggested a
competitive interaction between CxFV and WNV indi-
cating a possible early suppression of WNV replication
by CxFV infection in Cx. pipiens. Vector competence is
influenced by the time-point examined and by genetic
differences between mosquito populations [40] as well as
genetic diversity and fitness of a laboratory colonized
population [41, 42]. All these factors must be taken into
account for co-infection studies in mosquitoes.
The Cx. pipiens colony used in the present study was
naturally infected by Wolbachia spp. This may have
influenced the vector competence of infected mos-
quitoes as shown in a previous study [43]. Our re-
sults showed that RVFV was detected in bodies, legs/
wings or saliva of mosquitoes with (n = 27) and
without (n = 5) Wolbachia. Due to the small sample
size, further studies regarding this issue are needed
to explain the potential interference of Wolbachia in
arbovirus-vector interactions.
The present study and our previous report [29]
allow us to assure that the Cx. pipiens hybrid colony
of Gavà can become infected, disseminate and trans-
mit RVFV. The IR and DIR obtained were lower than
those reported by Turrell et al. [44] when a Cx.
pipiens hybrid colony was exposed to a similar RVFV
viral dose (107.5 PFU/ml) at 14 dpe. Regarding the
forms of Culex pipiens, RVFV was detected in
mosquito bodies, legs/wings and saliva of Cx. pipiens
form molestus (n = 26 tested). Thus, our findings in
the present work also showed that the individuals of
molestus form within the hybrid colony disseminated
and transmitted RVFV. However the virus was only
detected in mosquito bodies in hybrid form (n = 6).
These results may suggest that the individual form
might determine the RVFV dissemination and later
Fig. 4 RVFV Ct-values in female mosquito bodies and legs infected and non-infected with CxFV. RVFV loads in female mosquito bodies and legs/
wings were not affected by CxFV infection
Table 2 Presence of RVFV in different samples of mosquitoes with positive saliva at 14 dpe. Ct-values of positive samples analysed
by RT-qPCR are reported
Individuals Legs and wings Saliva Saliva (CPE) CxFV Wolbachia
Cx. pipiens molestus 22.76 32.40 - 29.49 -
Cx. pipiens molestus 22.43 30.55 - - +
Cx. pipiens molestus 23.70 34.13 - - +
Cx. pipiens molestus 24.10 32.54 - - +
Cx. pipiens molestus 25.00 38.39 - - +
Abbreviations: -, negative; +, positive; CPE cytopathic effect
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transmission, suggesting a strong midgut barrier in
hybrid form in Cx. pipiens individuals.
The insect’s immune responses largely determine the
viral load, extrinsic incubation period, and mortality of
the insect vector after viral infection, all of which dir-
ectly affect the outcome of disease transmission [45, 46].
Exposure to one microorganism can provide cross-
protection against another microorganism. Specific ex-
amples of the super-infection exclusion hypothesis based
on the idea of homologous interference, which is the
ability of an established infection with one virus to inter-
fere with secondary viral infection, has been documented
in cell culture not only with flaviviruses [47–50], but also
with other arboviruses of the genera Alphavirus [51],
Orbivirus [52] and Vesiculovirus [53, 54]. The study of
Bolling et al. [19] reported that CxFV could alter the
WNV infection on mosquitoes although it did not ex-
clude WNV infection. However, a positive correlation
between WNV and CxFV infection of field-collected Cx.
pipiens mosquitoes from Illinois has been observed, sug-
gesting that there could be a biological suppression that
mediates an increasing susceptibility to naturally WNV
infected mosquitoes [56]. Moreover, WNV transmission
was enhanced in the Honduras colony when mosquitoes
were inoculated simultaneously with WNV and CxFV
Izabal [20]. To our knowledge, nothing was known
about the potential interference of CxFV in the mos-
quito infection by other arboviruses not belonging to
Flavivirus genus. Our results, for the first time, indicate
that CxFV infection in Cx. pipiens might not alter the
immune system to interfere with the RVFV infection in
case of RVFV introduction in Cx. pipiens populations.
Conclusions
This is the first study to assess the potential interference
of an ISF on RVFV transmission. We have shown that
CxFV does not affect RVFV infection, dissemination and
transmission. Mosquitoes persistently infected at the
assessed conditions may not be used as a preventive
intervention strategy for blocking the transmission of
RVFV. Further studies using mosquitoes naturally in-
fected with CxFV should be performed to deepen the
knowledge in the natural CxFV infection and to eluci-
date consistent trends for RVFV vector competence in
CxFV artificially and naturally infected Cx. pipiens popu-
lations. Altogether, it is necessary to highlight the im-
portance of deepening the knowledge on the interaction
of ISF circulating in mosquito populations present in an
area where the potential pathogenic arboviruses can be
introduced in order to better assess arbovirus risk trans-
mission. Examining associations between insect-specific
viruses such as CxFV and RVFV and other arboviruses
important for human and animal health will provide sig-
nificant new insights into both arbovirus biology and
public health.
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